It’s football time…#Almost8

Currently crying down memory lane. My baby. 🥹😭❤️ #almost8

Its Not About No1 Nagin7 Epiosde Already Released On Jio Before Air On TV(almost8-10) Hour Before😏 So Chill #PriyankaChaharChoudhary

Odisha has 12328 sq km bamboo bearing area & in 4th position of Country's total bamboo forest cover & abundant forest resource in Odisha, with almost8% of total growing stock of Bamboo. It has uses: building material, paper pulp resource, scaffolding, food, agriculture implement

Mind you, I ghosted my hematologist almost8 years ago because I was sick and tired of iron transfusions. I’ve been raw dogging life since.

yes it is gunner did you actually see a list if yes show it to me i'd love to see it gunner is this list like ridding us of the aca and paying down our national. debt? oh wait he added almost8 trillion$to it. so show usthelist5gunner.ohialmost forgothe saidhecould endthehkrainewa

$nwbo @alphavestcap youtube.com/watch?v=dzcM0UsF… Earth right now this has the potential0:02 to do a 100x in share price from here0:04 but more importantly it has the0:07 potential to improve and extend the0:09 lives of cancer patients all over the0:11 world they have already proven that the0:13 new treatment works it's already been0:15 peer- reviewed and it's potentially0:18 applicable to all types of cancer0:20 according to all of the 100 plus World0:22 leading doctors that already peer0:25 reviewed the data and this company is0:27 also taking on the evil hedge funds that0:30 make billions in profits shorten0:32 companies just like this one this is the0:34 miraculous story of one small company0:37 changing the world while taking on the0:39 largest financial institutions on Earth0:41 in the most significant legal battle of0:44 this century and not only that but0:46 they've also just revolutionized the way0:48 we can now Mass create highly0:51 personalized vaccines even outside of0:53 this specific treatment which is a whole0:56 another story I'm about to breakdown in0:58 this tell all video this will be the1:00 most comprehensive video you've ever1:03 seen on nwbo and their massive potential1:05 to cure cancer make us investors rich1:08 and hopefully take down some of the1:11 hedge funds along the way in this video1:12 we're going to explore the historic1:14 phase three trial results of DC VXL how1:16 n wbo's acquisition of flask works is1:19 revolutionizing vaccine production1:22 across the globe and the multi-billion1:24 doll Revenue potential of Licensing D DC1:27 vac technology and treating most cancer1:29 types and the company's ongoing lawsuit1:32 against market makers for alleged1:34 spoofing and Market manipulation which1:36 could lead to Major Financial rewards1:39 for nwbo just know I'm not a financial1:41 adviser this is not Financial advice I1:44 do not represent nwbo nor was I paid by1:45 them to create this video I'm just a1:48 long-term investor and happy to share1:50 all of my knowledge for you for free I1:52 hope that's worth a like or subscribe1:54 and you'll consider sharing this video1:56 to spread awareness about this single1:57 great breakthrough cancer has ever seen1:59 before and don't take my word for it do2:02 your own DD starting right now what is2:04 Galo blastoma and why is it so difficult2:07 to treat GBM is one of the deadliest and2:09 most aggressive forms of cancer brain2:13 cancer specifically it accounts for2:15 nearly half of all manipulant brain2:17 tumors with about 13,000 cases diagnosed2:19 annually in the us alone here's why it's2:23 so challenging it has aggressive growth2:26 GBM grows in inedibly fast its cells2:28 divide quickly and spread into2:31 surrounding brain tissue making it2:32 nearly impossible to remove completely2:34 with surgery alone unlike many other2:36 cancers GBM doesn't stay contained it2:39 sends microscopic extensions into2:42 healthy parts of the brain often Out Of2:45 Reach of standard treatments that are2:47 available today and then it's resistance2:49 to therapy GBM is highly resistant to2:51 radiation and chemotherapy these2:54 treatments can kill some cancer cells2:56 but they rarely eliminate the tumor2:58 entirely while also subjecting other3:00 parts of you to toxic radiation and3:03 chemotherapy the cancer cells adapt3:05 quickly finding ways to survive even3:07 under aggressive treatment options that3:10 are available today which gives you3:12 limited survival rates current3:14 treatments like surgery radiation and3:16 chemotherapy offer very limited survival3:19 benefits the average patient lives only3:22 15 to 18 months after diagnosis today3:24 without this treatment the 5ar survival3:27 rate of GBM is less than 5% meaning less3:30 than 5% of people live more than 5 years3:33 currently with diagnosises not receiving3:37 DC VXL from nwbo making it one of the3:41 most devastating cancer diagnosises and3:44 then you have quality of life challenges3:47 as well treatments often come with3:48 severe side effects including cognitive3:50 decline fatigue and physical3:52 disabilities this makes the battle3:54 against GBM not only a fight for3:56 survival but also for quality of Life3:58 given these challenges GBM has been4:00 considered a death sentence by most4:02 that's why DC VX L's breakthrough is4:05 such a Monumental development by the way4:07 this presentation took me an4:10 extraordinary long time to create and4:11 it's compiled of thousands of hours of4:13 research that I've done over the years4:15 I'll include references to everything I4:17 say at the bottom of this and share this4:19 with my Discord Community which is Free4:21 by the way you can get all my classes4:23 live streams live trading sessions and4:25 all of my alerts on stocks options4:27 Futures and cryptos for free with the4:28 link in my top pin comment but what is4:31 DC VL and how does it work DC VXL is a4:33 personalized immunotherapy designed to4:37 teach the immune system to recognize and4:40 Destroy cancer cells unlike chemotherapy4:43 which indiscriminately targets all fast4:46 dividing cells including the healthy4:49 ones dcvl works with Precision sparing4:51 the healthy tissue here's how it works4:55 with the step-by-step process first they4:57 harvest dendritic cells doctors take a5:00 small sample of the patient's blood from5:02 this they extract the dendritic cells5:05 which act as the immune systems coaches5:07 if you will these cells play a crucial5:10 role teaching the immune system to5:13 recognize harmful Invaders like viruses5:15 bacteria or in this case cancer and then5:18 you have its tumor profiling after the5:20 patient undergo surgery to remove as5:23 much of the tumor as possible the tumor5:24 tissue is sent to a lab scientists then5:26 extract proteins from the tumor which5:29 serve as the Cancer's unique fingerprint5:32 these proteins are specific to the5:34 patient's tumor making the vaccine5:36 highly5:38 personalized then the dendritic cells5:39 are exposed to the tumor proteins in a5:41 lab this process trains them to5:44 recognize GBM cells as threats and then5:46 they inject the vaccine once the5:49 dendritic cells are trained they are5:51 injected back into the patient these5:53 cells then mobilize the immune system5:55 activating other cells like te- cells to5:57 attack and Destroy any remaining cancer6:00 cells so why is DC VXL different its6:02 personalized approach means each vaccine6:06 is custom made for the individual6:09 patient targeting their specific tumor6:11 not just a broad applicability of6:14 everybody's tumor and then it has immune6:16 system activation unlike chemotherapy6:18 which suppresses your immune system6:21 dcvax L enhances it turning the body's6:23 natural defenses into a powerful weapon6:26 against cancer and its broad6:28 applicability while it's designed for6:30 GBM the same process can be applied to6:32 other types of solid tumors making it a6:35 platform technology and applicable to6:38 almost all types of cancer I want to say6:41 that again it's a platform technology6:44 applicable to almost all types of cancer6:47 that Beed worth repeating and let's get6:50 into the phase three trial results which6:52 is a game-changing breakthrough in the6:54 phase three trial for DC VXL it just hit6:56 a historic Milestone it's the first6:59 trial in over 20 years to show a7:02 significant Improvement in survival7:04 rates for GBM patients GBM is the most7:05 lethal form of cancer by the way let's7:09 break it down as the results were posted7:12 in the JAMA Journal of Medical7:15 Association oncology which is a highly7:17 respected peer-reviewed medical journal7:19 the newly diagnosed patients patients7:22 who received DC VXL lived a median of7:24 19.3 months from random ation and7:27 22.4 months from surgery compared to7:31 only 162 months for the control group at7:34 the 24-month mark7:37 37.1% of DC vacl patients were still7:40 alive compared to only 24.9% in the7:43 control group and then you move on to7:47 the reoccurring GBM for patients who7:49 cancer had returned that's what7:52 recurrent means those treated with DC7:53 VXL lived a median of 13.2 month months7:56 compared to only 7.8 months for patients8:00 receiving the standard treatment of care8:03 prescribed today without dcvl this is8:05 nearly a 100% Improvement offering8:08 critical additional time for patients8:12 and families and then you also have the8:14 long-term survivors at the 4-year Mark8:16 15.7% of DC vacl patients were still8:19 alive compared to only 9.9% in the8:22 control group this suggests that DC VXL8:25 May provide a long-term remission for a8:28 subset of patients a result almost8:31 unheard of in GBM treatment without this8:33 and then getting into the safety profile8:37 out of over 2100 doses administered8:39 there were only five serious adverse8:41 side effects possibly related to the8:43 vaccine these included mild brain8:46 swelling and nausea far fewer and less8:48 severe than the side effects associated8:51 with chemotherapy or radiation alone8:54 these results aren't just numbers they8:57 represent hope for thousands of patients8:59 who previously had no options Beyond9:01 limited short-term treatments that were9:04 going to degrade their quality of life9:06 in hopes of barely extending their9:08 length of life then let's move on to9:10 expanding to other Cancers and how dcvax9:13 is actually a platform technology the9:16 science behind dcvax L isn't limited to9:19 GBM alone it can be applied to almost9:21 any type of solid tumor cancer including9:23 breast cancer lung cancer prostate9:26 cancer pancreatic cancer and coloral9:27 cancer um why solid tumor cancer9:30 specifically because solid tumors make9:33 up more than 90% of all cancer9:35 diagnosises unlike blood cancers like9:37 leukemia which are diffused solid tumors9:39 form masses that can be surgically9:42 removed and analyzed this makes them9:44 ideal for DC vac personalized approach9:47 which brings us to the revenue potential9:50 for treating multiple types of cancer9:51 globally there are 19.3 million new9:54 cancer cases each year if dcac or9:57 similar therapies treat just 10% of10:00 these cases at an average cost of about10:02 $100,000 per patient which is what nwbo10:04 is currently quoting that's a market10:07 worth nearly $200 billion annually10:09 expanding to additional cancer types and10:12 increasing adoption could push this10:14 number well beyond $300 billion annually10:16 that's only counting the few cancers10:19 that I just named above but because it's10:22 potentially applicable to all solid10:24 tumor cancers this could legitimately be10:25 worth trillions of dollar one day and by10:28 targeting a broad spectrum of cancers10:31 nwbo is poised to disrupt the entire10:33 oncology market and all cancer treatment10:36 companies May in fact end up licensing10:39 this technology at some point making10:41 this highly rewarding for long-term10:43 investors let's get into flask works and10:45 how it's revolutionizing vaccine10:48 production across the globe one of the10:50 biggest challenges in producing highly10:52 personalized cancer therapies like DC10:54 VXL has always been scalability10:56 each vaccine is custommade requiring10:59 labor intensive processes that can take11:02 weeks they are expensive and they limit11:04 the number of patients who can be11:07 treated that's where flask work comes in11:08 a groundbreaking technology that11:11 Northwest Biotherapeutics acquired to11:12 solve these production challenges what11:15 is flask Works flask works is an11:17 automated manufacturing platform11:20 designed specifically to produce11:22 personalized therapies like DC VXL it11:23 uses Advanced Robotics and prescription11:26 um Precision Engineering to streamline11:29 the production process how does it work11:32 well it automates the cell handling11:35 flask Works uses robots to handle the11:37 patient cells with Incredible accuracy11:39 this reduces the potential for human11:42 error ensuring each vaccine is11:44 consistent and safe and it has a faster11:45 production cycle traditional methods of11:48 creating personalized vaccines could11:50 take weeks and even months in some cases11:52 flask Works Cuts this time dramatically11:54 allowing vaccines to be ready in days11:57 and even hours and then it comes with an12:00 extraordinary cost efficiency by12:03 automating most of the process flask12:05 Works eliminates much of the manual12:07 labor traditionally involved reducing12:09 cost significantly this makes therapies12:11 like DC VXL more affordable and12:13 accessible to patients all around the12:15 world which brings it to its scalability12:17 flask Works can produce thousands of12:20 vaccines simultaneously whereas humans12:22 typically do them one at a time one12:25 person at a time one vac seen at a time12:27 this scalability is critical for12:30 bringing personalized treatments like DC12:32 VXL to the global market and makes the12:33 flask Works technology extremely12:36 attractive to all types of personalized12:38 therapies not just dcel and nwbo now12:40 owns flask works so to use this12:45 technology and automated system all12:47 other companies will have to pay nwbo to12:49 do so why is this a GameChanger flask12:52 Works doesn't just make DC VXL faster12:55 and cheaper to produce it makes it12:58 possible to treat far more patients than13:00 ever before for a therapy like DC VXL to13:02 have widespread adoption production must13:04 be efficient reliable and scalable and13:07 flask Works makes all of that a reality13:10 and by the way in the past the FDA told13:13 nwbo that they were going to have to be13:16 able to mass-produce this if they ever13:18 wanted them to sign off on it on the13:20 future so additionally flask Works13:21 positions Northwest Biotherapeutics as a13:24 leader in the field of automated Cale13:26 therapy Manufacturing this expertise13:27 could be licensed out to other companies13:30 opening new revenue streams which brings13:32 us to the licensing of dcvax Technology13:34 unlocking the global potential dcvax is13:36 more than just a treatment it's a13:39 platform technology that means the same13:41 basic principles that make DC VXL13:44 effective for GBM can be adapted to13:46 treat many other types of cancers here's13:49 how licensing this technology could13:51 unlock enormous potential for Northwest13:52 Biotherapeutics which trades on the OTC13:55 market by the way so you're not going to13:57 find this one on Robin Hood or Weeble13:58 you're going to need a broker like14:01 Charles Schwab Fidelity or thinker swim14:02 to trade nwbo stock so how does14:05 licensing work well it has collaboration14:07 with Pharma Giants nwbo can partner with14:10 other pharmaceutical companies granting14:13 them the rights to use the dcvax14:15 technology to develop it treatments for14:17 other specific types of cancers and then14:19 that creates a revenue structure for it14:22 licensing agreements typically include14:23 upfront payments Milestone payments and14:25 royalties upfront payments mean a14:27 company pays nwbo for the right to use14:29 the technology Milestone payments could14:31 include payments that are made as the14:33 partner company reaches development and14:35 Regulatory goals and royalties mean nwbo14:38 would earn a percentage of the revenue14:41 from any therapies developed using the14:42 dcvax technology and we could be looking14:44 at all three sorts of Revenue14:47 opportunities for nwbo and then it goes14:48 into the global reach by licensing dcx14:51 technology nwbo doesn't have to build14:54 infrastructure or distribution networks14:56 in every country partnering with already14:58 established pharmaceutical companies15:01 enables the technology to reach patients15:02 worldwide much faster which unlocks more15:04 Revenue potential and the billion dollar15:07 opportunity for15:10 nwbo licensing could generate billions15:11 of dollars annually in revenue for nwbo15:14 without the company having to bear the15:17 cost of developing and marketing every15:19 new therapy themselves for example if a15:20 partner develops a breast cancer15:23 treatment using DC vax and earns five515:25 billion annually15:28 nwbo could earn hundreds of millions per15:29 year in royalties but that's just one15:31 piece of the puzzle let's explore the15:34 broader Revenue potential including15:36 licensing buyouts and share price15:37 implications of all three individually15:40 and combined number one obviously it can15:42 treat multiple types of cancer we15:46 already know that it can do that breast15:47 cancer lung cancer pancreatic cancer15:49 prostate cancer colcol cancer that I15:51 just named a minute ago for you which15:53 brings the current Revenue estimates so15:55 if nwbo captures just 10% of the global15:57 solid tumor Market assuming on average16:00 the treatment cost $100,000 per patient16:02 the total Market size would be16:04 approximately $200 billion annually16:05 scaling this to broader range of cancers16:07 could increase the market size to $30016:10 $300 billion dollar or more annually16:12 making n wbo's dcv platform one of the16:14 most valuable assets in oncology on just16:17 that 10% estimate alone but we also have16:20 licensing potential on top of that the16:23 licensing potential means nwo's patent16:25 portfolio and platform technology te16:27 ology makes it an ideal candidate for16:29 licensing agreements with other biotech16:31 and pharmaceutical companies licensing16:33 allows nwbo to generate Revenue while16:35 leveraging the resources of larger16:37 companies to develop therapies for16:39 additional cancers the key feature of16:41 these licensing deals may be upfront16:43 payments Milestone payments and16:45 royalties that we just discussed and16:46 then you have um the potential revenue16:48 from licensing if just five major16:50 pharmaceutical companies licens dcvax16:53 technology to develop treatments for16:55 other cancer types n WBO could earn16:57 easily $5 to10 billion annually in16:59 Combined upfront Milestone and royalty17:01 payments from that and then you also17:03 have um considering all of the top17:05 biotech buyouts nwbo could at one day17:08 possibly be bought out so let's explore17:11 what that might look like nwo's17:13 potential success with DC vax positions17:16 it as a prime target for acquisition by17:17 a larger biotech or pharmaceutical17:20 company history has shown that companies17:22 with groundbreaking cancer therapies17:24 often become buyout targets leading to17:26 Mass evaluations here are five of the17:28 largest biotech bouts history buyouts in17:31 history and what they mean for17:34 nwbo cellgene was acquired by Bristol17:36 Meyers in 2019 for $74 billion and it17:39 really only treated one thing then you17:43 have Genentech acquired for $46 billion17:45 and it had breakthrough Cancer drugs17:49 like aist and hertin I'm not going to17:51 pretend I know how to say all these17:53 medical terms I'm not a doctor I've just17:54 been researching this company as an17:57 investor for many years as all so please17:58 forgive me for butchering the name of18:00 all this medical jargon I'm doing the18:02 absolute best I can and it took me an18:03 extraordinarily long time to create this18:05 presentation for you but anyways moving18:07 on you got another buyout right here for18:08 $39 billion another buyout for $2118:10 billion another buyout for $21 billion18:12 and most of these companies only had one18:14 single product that the larger company18:16 wanted to buy from them but DC VXL is18:19 potentially obliga to all solid tumor18:22 cancers right so it's not just one18:23 cancer treatment that they're looking to18:25 buy they'd be buying the entire uh um18:26 dcac platform technology potentially18:29 plus they'd be looking to buy flask18:33 Works potentially which is an entirely18:34 separate Venture and Avenue there so I18:36 believe nwbo is looking at much higher18:39 valuations than these top five that I18:41 just listed here and that highest one18:43 was $74 billion so it's my personal18:44 belief we're looking at a buyout way18:46 bigger than $74 billion if nwbo ever18:48 chooses to go the buyout route which I'm18:52 not so sure they'll do buyout alone but18:55 that's the possibility that we're18:57 exploring here so moving on if it if18:58 nwbo achieves widespread adoption of DC19:03 VX and expands its platform to19:05 additional cancer types it could attract19:06 B offers similar to the largest biotech19:08 deals obviously um so what are the19:10 valuation scenarios with a 10% market19:13 share in a $200 billion Market nwbo19:15 could achieve a valuation of 20 to $3019:17 billion easily its current market cap is19:19 less than 400 million dollar as I filmed19:21 this mind you and it's only trading at19:23 just 29 cents per share right now at19:25 this valuation and assuming assuming19:27 approximately 1 billion shares19:28 outstanding a buyout would translate to19:30 a share price of about $ 20 to $30 per19:32 share and it's only 29 cents per share19:34 right now making this an easy 10 to19:36 1,000 X right now and in a19:38 scenario where nwbo captures additional19:41 market share or expans licensing a $5019:43 billion valuation could push the share19:46 price to $50 per share or higher and19:48 then let's look at the combined19:53 opportunity of Licensing and buyout nwbo19:54 doesn't need to rely solely on buyout19:57 for succcess it can pursue both19:59 licensing and acquisition opportunities20:01 maximizing its Revenue potential and I20:04 think we might see something more along20:06 these lines so a buyout valuation gives20:07 us an estimation of 20 to 50 billion20:10 depending on the market adoption and20:12 platform expansion but I think that's a20:13 conservative but fair estimate there and20:15 then you have its licensing Revenue20:18 which I estimate to be5 to10 billion20:19 annually from ongoing agreements with20:21 pharmaceutical partners and I think20:23 that's still conservative honestly so20:25 this dual strategy nwbo can capture the20:27 full value of its technology while20:29 providing flexibility for future growth20:31 and then by looking at these top buyouts20:34 licensing models and revenue scenarios20:36 it's clear that Northwest20:38 Biotherapeutics has positioned itself20:39 for significant success whether through20:41 Partnerships Acquisitions or both the20:43 company's potential impact on the20:46 oncology market and its valuation cannot20:47 be20:50 overstated and then let's talk about the20:51 Synergy with other Cancer Treatments one20:53 of the most exciting aspects of DC VXL20:55 is that it doesn't compete with existing20:58 Cancer Treatments it complement them21:00 this makes it a valuable addition to the21:03 cancer treatment Arsenal rather than a21:05 replacement for existing therapies21:07 because if you stand to replace the21:09 current treatments being prescribed21:11 today you risk those big Revenue21:13 generating companies shutting you down21:15 either by killing you in legal fees and21:17 court costs buying you out and shelving21:19 the product forever or just plain21:21 killing you outright in the street like21:23 a dog all of which of these have been21:26 done to previous cancer breakthroughs in21:28 the past but none of that needs to be21:29 applied here because it works with these21:32 other leading treatments of today so how21:34 does it work with the standard21:37 treatments well with chemotherapy and21:38 radiation while chemo and radiation work21:40 to shrink tumor cells and care and kill21:42 the cancer cells along with basically21:45 all of your other target cells in that21:47 Target area both healthy and cancerous21:48 cells alike dcx L trains the immune21:51 system to Target any cancer cells that21:54 remain preventing recurrence and only21:56 targeting the unhealthy cancerous cells21:58 leaving your healthy cells intact and22:01 then you have its checkpoint Inhibitors22:04 um which is a breakthrough for nwbo22:06 drugs like these that I can't pronounce22:09 release the breakes on the immune system22:12 allowing it to attack cancer cells more22:14 aggressively dcvax L enhances this22:16 effect by teaching the immune system to22:19 specifically recognize the cancer cells22:22 specifically and then you have the22:26 surgical removal of tumors of course DC22:27 vac Cel is administered after surgery22:30 targeting residual cancer cells that are22:32 often Left Behind which reduces the risk22:35 of cancer returning so why is22:37 collaboration better than competition22:40 most pharmaceutical companies might view22:42 new treatments as threats to their22:44 existing profits and therapies however22:46 DC Vel complimentary nature reduces this22:49 concern instead of replacing other22:52 treatments it

Bless you Sis Deborah 💜🙏🏾 my babies started school this week - our Baby D is our lil guy now #Almost8

The other day i got the cutest picture of my babygirl 🥰 #shadowrae #almost8 #julybaby @AlastorFan4355

it’s been exactly 7 almost8 hours after the incident and my body is still numb

I've had enough of this man🙄. Can you picture having someone like this in your life for four decades🥱⁉️ He pretends to be a friend but is actually trying to undermine you, prioritizing personal gain over friendship and fame over loyalty.🤦🏾‍♀️🐍‼️#Almost8

and that’s exactly why I don’t hold peoples kids, didn’t even hold my niece until she was almost8 months 💀

Lità民のかびちゃん🐏と skyデート(*˘︶˘*).｡.:*♡ 羽も4枚羽が7枚（Almost8枚）ଓ エモート5個しかなかったのにたくさん♡⸝ဗီူ⸜⸝ဗီူ⸜♡ 4時間もキャリーしてくれてありがとう(⑉꒦ິ^꒦ິ⑉) 私ただただお手手繋いでもらってるか、 おんぶしてもらってた(｡º̩̩́⌓º̩̩̀).💕 バグってもかわいいsky😍 #sky #sky星を紡ぐ子どもたち #Litàクラン #Lità民 #Litàファミリー

When you ask your oldest where he wants to go for his “early “ birthday weekend 🎉🎂🥳he tells @YacobozziMrs he wants to go to the 🚄🚅🚂museum in @VisitSavannah 🚙🛣️sorry @OfficialOPLive @OnPatrolNation @OnPatrolLive Please slow down, your growing to fast🥹😭😢#almost8

My sonshine💗💙! I love him so much! A genius, but still waiting to hear his voice. Will be a college grad but who knows where 😊. #almost8 #Collegebound #RYSWVSU

Morning art fun with 6 (topL) and almost8 (bottomL), and a watercolor kit from @letsgomakeart I tried to add a discreet #bigfoot to my 2nd attempt (bottomR) 😅 And the inspo pic

Let’s get this right. You may lose the house,you could have a 5050 senate inflation is almost8% this month.Gas prices will rise dramatically when the SPR are depleted and his standing in the world is almost 3rd world status. And you are giving away 100s of billions to foreigners

That’s like 8% of our total pop. There’s an unemployment rate at almost8%. But you want to bring more people ! You haven’t dealt with anything, you wear a lot of costumes though ! Maybe start with clean drinking water for the Canadians who pay you sir !

Two years ago 😭 Pumpkin patch 🎃 ready! #Almost8

Birthday celebrations! #mygirl #almost8 ♥️